Launch of TerugBetaalRegeling Elvanse®

12 August 2019

Launch of TerugBetaalRegeling Elvanse®

The health insurer does not fully reimburse Elvanse® 20, 30, 50 and 70mg. The producer of this medicine has therefore asked TBR Nederland to reimburse the Personal Contribution to the patient.


The Personal Contribution for Elvanse® that is demonstrably charged to the patient by the health insurer will be fully reimbursed from 12 August 2019 up to a maximum of € 250 per patient per year. 

Who can submit a claim

Only patients or their carer can claim the Personal Contribution for Elvanse® 20, 30, 50 and 70mg online or by post. Pharmacists cannot claim this medicine on behalf of the patient.

For more information check out the Elvanse® medicine page 

You are currently offline. Some pages or content may fail to load.